Edition:
United Kingdom

National Holdings Corp (NHLD.OQ)

NHLD.OQ on NASDAQ Stock Exchange Capital Market

3.27USD
17 Jan 2019
Change (% chg)

-- (--)
Prev Close
$3.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,601
52-wk High
$4.91
52-wk Low
$2.69

Latest Key Developments (Source: Significant Developments)

B. Riley Enters Definitive Agreement To Purchase Fortress Biotech’S Stake In National Holdings Corp
Monday, 19 Nov 2018 

Nov 19 (Reuters) - National Holdings Corp ::B. RILEY FINANCIAL ENTERS A DEFINITIVE AGREEMENT TO PURCHASE FORTRESS BIOTECH’S STAKE IN NATIONAL HOLDINGS CORPORATION.NATIONAL HOLDINGS CORP - DEAL FOR $3.25 PER SHARE.NATIONAL HOLDINGS CORP - DEAL FOR APPROXIMATELY $22.9 MILLION.NATIONAL HOLDINGS CORP - B. RILEY WILL PURCHASE 7 MILLION SHARES OF NATIONAL FROM FORTRESS.NATIONAL HOLDINGS CORP - B. RILEY THROUGH UNIT ENTERED AGREEMENT TO ACQUIRE FORTRESS BIOTECH'S MAJORITY STAKE IN CO.  Full Article

Fortress Biotech Announces Agreement To Sell Its Majority Stake In National Holdings Corp
Monday, 19 Nov 2018 

Nov 19 (Reuters) - Fortress Biotech Inc ::PRESS RELEASE - FORTRESS BIOTECH ANNOUNCES AGREEMENT TO SELL ITS MAJORITY STAKE IN NATIONAL HOLDINGS CORPORATION TO NHC HOLDINGS, LLC, A WHOLLY-OWNED SUBSIDIARY OF B. RILEY FINANCIAL.FORTRESS BIOTECH INC - 24.0 PERCENT OF NATIONAL WAS SOLD IN INITIAL CLOSING ON NOVEMBER 16 AT $3.25 PER SHARE.FORTRESS BIOTECH - 32.1 PERCENT STAKE TO BE SOLD AT SAME PER-SHARE PRICE FOLLOWING FINRA APPROVAL, FOR AGGREGATE PURCHASE PRICE TOTALING ABOUT $22.9 MILLION.  Full Article

National Holdings Reports Q2 Loss Per Share Of $0.18
Tuesday, 15 May 2018 

May 15 (Reuters) - National Holdings Corp ::ORATION REPORTS FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER 2018.Q2 REVENUE ROSE 16 PERCENT TO $60.3 MILLION.Q2 LOSS PER SHARE $0.18.  Full Article

Volitionrx Announces Proposed Underwritten Public Offering
Thursday, 8 Mar 2018 

March 8 (Reuters) - Volitionrx Ltd ::VOLITIONRX ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.VOLITIONRX LTD - ‍INTENDS TO USE NET PROCEEDS OF OFFERING FOR CONTINUED PRODUCT DEVELOPMENT, CLINICAL STUDIES, PRODUCT COMMERCIALIZATION​.  Full Article

National Holdings Q1 EPS $0.41
Wednesday, 15 Feb 2017 

National Holdings Corp : National Holdings Corporation reports fiscal first quarter 2017 results . Q1 revenue $44.6 million versus $39.6 million .Q1 earnings per share $0.41.  Full Article

Fortress Bio to sell majority stake in brokerage National Holdings

Fortress Biotech Inc said on Monday it will sell its majority stake in the independent wealth management firm National Holdings Corp , bringing an end to an unusual ownership arrangement that had drawn scrutiny from the investing and securities industries.

No consensus analysis data available.